Jeff Yass’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Jeff Yass’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-31,500	Closed	-$1.73M	–	14873
2022 Q2	$1.73M	Buy	+31,500	New	+$1.65M	﹤0.01%	5222

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Jeff Yass's SRRA Position: Q2 2022 in Review

Jeff Yass sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 66,400 shares — an estimated $3.48M sold.

Jeff Yass first reported a position in SRRA in Q4 2015 and held it in 10 quarters. The position peaked at $2.13M in Q1 2022. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

Jeff Yass reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Jeff Yass sold 66,400 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $3.48M.
Jeff Yass first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
Jeff Yass's Sierra Oncology, Inc. Common Stock position peaked at $2.13M in Q1 2022.
109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.